Myriad Genetics, Inc. MYGN recently launched a patient home collection kit for its GeneSight Psychotropic test, enabling the DNA sample collection that is generally undergone in a clinician’s office ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results